Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II evaluation of carzelesin in NHL

June 24, 1998

Miproxifene phosphate, a promising treatment for breast cancer

June 24, 1998

Management strategy including hydroxyurea successful in unresectable meningioma

June 24, 1998

S-16020-2: a topoisomerase II inhibitor selective for renal cancers heads for phase II testing

June 24, 1998

Select Therapeutics signs agreement for cancer vaccine platform technology

June 24, 1998

Lilly presents results of first clinical trial evaluating the MDR modulator LY-335979

June 23, 1998

Czech investigators describe novel CDK inhibitor with potent antitumor activity

June 23, 1998

SB-RA-131012, an MDR-reversing taxane

June 23, 1998

Enzon allowed patent on its PEG technology

June 23, 1998

ZD-1839, an EGFR-TK inhibitor worthy of further testing

June 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...